SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Gopinath SD, Rando TA. Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell 2008; 7: 590598.
  • 2
    Decary S, Hamida CB, Mouly V et al. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord 2000; 10: 113120.
  • 3
    Collins CA, Olsen I, Zammit PS et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005; 122: 289301.
  • 4
    Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961; 9: 493495.
  • 5
    Carlson BM, Faulkner JA. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol 1989; 256: C1262C1266.
  • 6
    Collins CA, Zammit PS, Ruiz AP et al. A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 2007; 25: 885894.
  • 7
    Shefer G, Van de Mark DP, Richardson JB et al. Satellite-cell pool size does matter: Defining the myogenic potency of aging skeletal muscle. Dev Biol 2006; 294: 5066.
  • 8
    Smythe GM, Shavlakadze T, Roberts P et al. Age influences the early events of skeletal muscle regeneration: Studies of whole muscle grafts transplanted between young (8 weeks) and old (13–21 months) mice. Exp Gerontol 2008; 43: 550562.
  • 9
    Lee CE, McArdle A, Griffiths RD. The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clin Nutr 2007; 26: 524534.
  • 10
    Conboy IM, Conboy MJ, Wagers AJ et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005; 433: 760764.
  • 11
    Brack AS, Conboy MJ, Roy S et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007; 317: 807810.
  • 12
    Hidestrand M, Richards-Malcolm S, Gurley CM et al. Sca-1-expressing nonmyogenic cells contribute to fibrosis in aged skeletal muscle. J Gerontol A Biol Sci Med Sci 2008; 63: 566579.
  • 13
    Goldspink G, Fernandes K, Williams PE et al. Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscul Disord 1994; 4: 183191.
  • 14
    Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J 2008; 411: 118.
  • 15
    Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199210.
  • 16
    Brunelli S, Rovere-Querini P. The immune system and the repair of skeletal muscle. Pharmacol Res 2008; 58: 117121.
  • 17
    Renault V, Thornell LE, Eriksson PO et al. Regenerative potential of human skeletal muscle during aging. Aging Cell 2002; 1: 132139.
  • 18
    Gargioli C, Coletta M, De Grandis F et al. PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat Med 2008; 14: 973978.
  • 19
    Heslop L, Morgan JE, Partridge TA. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 2000; 113: 22992308.
  • 20
    Morgan JE, Fletcher RM, Partridge TA. Yields of muscle from myogenic cells implanted into young and old mdx hosts. Muscle Nerve 1996; 19: 132139.
  • 21
    Morgan JE, Gross JG, Pagel CN et al. Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J Cell Biol 2002; 157: 693702.
  • 22
    Callicott RJ, Womack JE. Real-time PCR assay for measurement of mouse telomeres. Comp Med 2006; 56: 1722.
  • 23
    Kelly R, Alonso S, Tajbakhsh S et al. Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J Cell Biol 1995; 129: 383396.
  • 24
    Tajbakhsh S, Bober E, Babinet C et al. Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev Dyn 1996; 206: 291300.
  • 25
    Beauchamp JR, Heslop L, Yu DS et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000; 151: 12211234.
  • 26
    Gross JG, Bou-Gharios G, Morgan JE. Potentiation of myoblast transplantation by host muscle irradiation is dependent on the rate of radiation delivery. Cell Tissue Res 1999; 298: 371375.
  • 27
    Gross JG, Morgan JE. Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve 1999; 22: 174185.
  • 28
    Muntoni F, Mateddu A, Marchei F et al. Muscular weakness in the mdx mouse. J Neurol Sci 1993; 120: 7177.
  • 29
    Pastoret C, Sebille A. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 1995; 129: 97105.
  • 30
    Goyns MH, Lavery WL. Telomerase and mammalian ageing: a critical appraisal. Mech Ageing Dev 2000; 114: 6977.
  • 31
    Decary S, Mouly V, Hamida CB et al. Replicative potential and telomere length in human skeletal muscle: Implications for satellite cell-mediated gene therapy. Hum Gene Ther 1997; 8: 14291438.
  • 32
    Pastoret C, Sebille A. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve 1995; 18: 11471154.
  • 33
    Lund TC, Grange RW, Lowe DA. Telomere shortening in diaphragm and tibialis anterior muscles of aged mdx mice. Muscle Nerve 2007; 36: 387390.
  • 34
    Sacco A, Doyonnas R, Kraft P et al. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008; 456: 502506.
  • 35
    Harris JB. Myotoxic phospholipases A2 and the regeneration of skeletal muscles. Toxicon 2003; 42: 933945.
  • 36
    Blaveri K, Heslop L, Yu DS et al. Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Dev Dyn 1999; 216: 244256.
  • 37
    Boldrin L, Morgan JE. Activating muscle stem cells: Therapeutic potential in muscle diseases. Curr Opin Neurol 2007; 20: 577582.
  • 38
    Zammit PS. All muscle satellite cells are equal, but are some more equal than others? J Cell Sci 2008; 121: 29752982.
  • 39
    Reimann J, Irintchev A, Wernig A. Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice. Neuromuscul Disord 2000; 10: 276282.
  • 40
    Degens H. Age-related skeletal muscle dysfunction: Causes and mechanisms. J Musculoskelet Neuronal Interact 2007; 7: 246252.
  • 41
    Partridge TA, Morgan JE, Coulton GR et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989; 337: 176179.
  • 42
    Morrison J, Lu QL, Pastoret C et al. T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab Invest 2000; 80: 881891.
  • 43
    Farini A, Meregalli M, Belicchi M et al. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. J Pathol 2007; 213: 229238.
  • 44
    Groma V. Demonstration of collagen type VI and alpha-smooth muscle actin in renal fibrotic injury in man. Nephrol Dial Transplant 1998; 13: 305312.
  • 45
    Specks U, Nerlich A, Colby TV et al. Increased expression of type VI collagen in lung fibrosis. Am J Respir Crit Care Med 1995; 151: 19561964.
  • 46
    Naugle JE, Olson ER, Zhang X et al. Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am J Physiol Heart Circ Physiol 2006; 290: H323H330.
  • 47
    Pagel CN, Partridge TA. Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J Neurol Sci 1999; 164: 103116.
  • 48
    Lefaucheur JP, Pastoret C, Sebille A. Phenotype of dystrophinopathy in old mdx mice. Anat Rec 1995; 242: 7076.
  • 49
    Tseng BS, Zhao P, Pattison JS et al. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol 2002; 93: 537545.
  • 50
    Wineinger MA, Abresch RT, Walsh SA et al. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil 1998; 77: 2027.
  • 51
    Wakeford S, Watt DJ, Partridge TA. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 1991; 14: 4250.
  • 52
    Beauchamp JR, Morgan JE, Pagel CN et al. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999; 144: 11131122.
  • 53
    Zhang MM, Gopal AK. Radioimmunotherapy-based conditioning regimens for stem cell transplantation. Semin Hematol 2008; 45: 118125.
  • 54
    Wallace GQ, Lapidos KA, Kenik JS et al. Long-term survival of transplanted stem cells in immunocompetent mice with muscular dystrophy. Am J Pathol 2008; 173: 792802.
  • 55
    Prochazka M, Gaskins HR, Shultz LD et al. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A 1992; 89: 32903294.
  • 56
    Serreze DV, Leiter EH, Hanson MS et al. Emv30null NOD-scid mice. An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 1995; 44: 13921398.
  • 57
    Chamberlain JS, Metzger J, Reyes M et al. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 2007; 21: 21952204.